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Abstract 
Background/Aim: Chronic low back pain (CLBP) is a global musculoskeletal 
challenge, resulting in pain and disability on individuals. Laser therapy can be 
used to treat CLBP. This review evaluates the effectiveness of laser therapy 
including high level laser therapy (HLLT) and low level laser therapy (LLLT) 
on CLBP in relation to pain or functional disability. 
 
Methods: The authors conducted a systematic review of randomised 
controlled trials (RCTs) and searched the Cochrane Library, MEDLINE, 
CINAHL, AMED and PEDro from their start to June 2015. All studies that met 
predetermined inclusion and exclusion criteria were appraised with The 
Cochrane Collaboration’s tool for assessing risk of bias and Critical Appraisal 
Skills Programme Tools in June, 2015.  
 
Findings: Six RCTs met the inclusion criteria: two RCTs reported significant 
improvement in pain and functional disability with the use of HLLT but with 
small sample size (n=103); one RCTs (n=61) reported significant 
improvement and three RCTs (n=215) reported insignificant improvement in 
pain and functional disability with the use of LLLT. 
 
Conclusion: On the strength of the evidence available HLLT and LLLT are 
not currently recommended to be replaced or be offered in addition to 
conventional treatment. Further rigorous research is required to confirm the 
potential use of laser therapy on individuals presenting with CLBP. 
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Background 
Low back pain (LBP) is a common musculoskeletal problem in adult 
(Diamound and Borenstein, 2006), where Hoy et al. (2012) stated a lifetime 
prevalence up to 85%, a mean estimated point prevalence is approximately 
11.9% and recurrence rate at 1 year ranges from 24% to 80%. Walker (2000) 
estimated 65% of those who recur will eventually develop chronic low back 
pain (CLBP). 
  
The National Institute for Health and Care Excellence (NICE, 2009) 
recommended physiotherapy intervention is effective in the early 
management of persistent non-specific LBP; however, clinically there is no 
standardised approach due to patients’ differences and therapists’ 
background and preferences. NICE (2009) recommends exercise therapy, 
acupuncture and manual therapy as primary treatment for early management 
of persistent non-specific LBP; however, all electrotherapy modalities 
including laser therapy are excluded from the recommendation list; this is due 
to a lack of rigorous evidence. 
 
The European guidelines for the management of chronic non-specific low 
back pain (Airaksinen et al., 2004) also did not recommend laser therapy for 
the management of chronic low back pain due to conflicting evidences and 
limited evidence that showed there was no difference in effectiveness 
between laser therapy, laser therapy and exercise, and exercise. Likewise, 
the American College of Physicians and the American Pain Society clinical 
guideline for diagnosis and treatment for low back pain (Chou et al., 2007) 
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concluded that there was insufficient evidence to recommend to LLLT, as the 
evidence was poor and therefore it was unable to estimate to net benefit. 
The latest systemic review (Yousefi-Nooraie et al. 2008) investigated the 
effectiveness of low-level laser therapy (LLLT) on pain relief and functional 
disability in LBP patients and also concluded that due to the heterogeneity of 
data, there were insufficient data to draw firm conclusions on the positive 
clinical effects of LLLT for LBP.  
 
Nevertheless, the evidence from Timimi et al. (2010) has not been taken into 
account in any systematic review or clinical guideline yet where the 
effectiveness of high-level laser therapy (HLLT) on CLBP management has 
not been reviewed. This review aims to evaluate the effectiveness of laser 
therapy including both HLLT and LLLT on CLBP in relation to pain relief and 
improving functional disability.  
 
Laser therapy 
Laser or “Light Amplification by Stimulated Emission of Radiation” therapy is 
a medical treatment that uses concentrated light beam. Laser characterised 
by the properties of monochrome, coherence and collimation. Under the U.S 
Food and Drug Administration laser classification system, laser therapy is 
categorised into LLLT and HLLT. HLLT is referred to Class IV laser with a 
limited average power more than 500mw and up to 7500mW, where LLLT is 
usually referred to Class III laser with a limited average power up to 500mW 
(Conforti and Fachinetti, 2013). Both LLLT and HLLT have a wavelength 
range of about 600nm – 1000nm, depending on which type of laser it is. 
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Although the popularity of HLLT is increasing, there is no recommended 
dosage by any clinical guideline or association yet; while World Association of 
Laser Therapy (2010) recommends LLLT dosage as below:  
 
1. 4 points of laser head;  
2. minimum 1J per point;  
3. peak pulse output is higher than 1W,  
4. mean output is higher than 5mW;  
5. power density is higher than 5mW/cm2;  
6. irradiation times should range between 30 seconds and 600 seconds;  
7. and the frequency of receiving treatment is daily treatment for 2 
weeks or having treatment every other day for 3 to 4 weeks. 
 
The effectiveness of HLLT and LLLT remains controversial with conflicting 
evidences. However, Huang et al. (2011) reported both in vivo and in vitro 
trials indicated positive results of LLLT and suggested there is a biphasic 
dose response in LLLT, which suggests HLLT theoretically may exceed the 
optimal therapeutic dosage; however, this phenomenon was not reported in 
any clinical trials (Huang et al., 2011) and two RCTs (Conforti and Fachinetti, 
2013; Kheshie et al., 2014) reported a significant pain reduction effect with 
the use of HLLT on musculoskeletal problems.  
 
The mechanism of laser therapy was hypothesised to be directly link to the 
absorption of monochromatic visible and near infrared radiation by 
components of the cellular respiratory chain (Kaur 1989). Application of LLLT 
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induces photobiological process and during this process, it increases proton 
electrochemical potential (Huang et al., 2011) and stabilises cellular 
membrane (Lubart et al., 2000; Karu et al., 2001), increased ATP synthesis 
and production (Passarella et al. 1994; Ferraresi et al., 2014) and increased 
mitochondrial membrane potential (Huang et al., 2011), increased RNA and 
protein synthesis (Greco et al. 1989), achieve local vasodilation induced by 
the nitrogen oxide that is dissociated from intracellular store (Shiva and 
Gladwin, 2009), enhances lymphocyte response (Stadler et al., 2000), blocks 
depolarisation of C-fiber afferent nerves (Tsuchiya K et al, 1993). In overall, 
these physiological and cellular responses can ultimately reduce 
inflammation, pain and healing time and therefore in theory, laser therapy can 
reduce pain and improve functional disability on the management of CLBP. 
 
Biphasic dose response in LLLT in cell cultures was reported (Huang et al., 
2011),  
 
Methodology 
Criteria for consideration of studies for this review 
See: PICOS (table 1) 
-------------------------------------------insert table 1------------------------------------------ 
Type of studies 
Published reports of completed RCTs were included. There were no 
restrictions on date of trial but had to be English-language studies. 
 
Type of participants 
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Included 
Trials that included male or female subjects with non-specific CLBP who 
aged 18 years old or above but less than 60 years old were included, where 
CLBP is defined as pain localised between the rib cage and the folds of 
buttocks, with or without referred symptoms to the legs that lasts more than 6 
weeks (NICE, 2009).  
 
Excluded 
Trials that included subjects with CLBP caused by extraspinal source such as 
rheumatological conditions, fractures, osteoporosis, infection, metastatic 
diseases, dysvascularity, neoplasms, gastrointestinal causes, psychological 
disorder, or other auto-immune disease were excluded as Yousefi-Nooraie et 
al. (2007) and NICE (2009) suggested. 
 
Type of Intervention 
Laser therapy can be subdivided into HLLT and LLLT. The difference between 
them is the amount of energy delivered to achieve therapeutic effects. This 
review included reports of studies which investigated the effects of all form of 
HLLT and LLLT, including all wavelengths, all irradiance and all source of 
laser, in comparison to any other treatment modalities. This comparison 
could be no treatment, sham procedures (Basford et al., 1999; Djavid et al., 
2007; Ay et al., 2010), any form of laser therapy with other therapeutic 
intervention (Gur et al., 2003; Djavid et al., 2007; Ay et al., 2010; Alayat et al., 
2014) or the use of other therapeutic interventions alone (Fiore et al., 2011). 
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Type of outcome measures 
The selected patient reported outcome measures were either conducted 
through verbal questioning or by filling in a questionnaire. They were:  
 
1. CLBP intensity measured by visual analogue scale (VAS) (Ogon et 
al., 1996), numerical rating scale (NRS) (Ferreira-Valente et al., 2011) 
or other validated outcome measures.  
2. CLBP-related disability measured by the Oswestry disability index 
(ODI) (Fairbank and Pynsent, 2000), Roland-Morris Disability 
Questionnaire (RMDQ) (Roland and Fairbank, 2000), or any modified 
version and validated outcome measures. 
 
To be included in this review, studies had to have measured at least one of 
these outcomes at baseline and during follow-up. 
 
Search methods for identification of studies 
This review was done by the two authors and they searched 5 databases: 1. 
AMED (1998 to June 2015); 2. CINAHL (1992 to June 2015); 3. Cochrane 
Library (to June 2015); 4. MEDLINES (1979 to June 2015); and 5. PEDro (to 
June 2015) with specific search term (appendix 1), then articles were 
screened by inclusion and exclusion criteria (appendix 2). See PRISMA 
flowchart for details (figure 1). 
 
Data Extraction and Analysis  
The authors extracted the information about the data on study design, 
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participants, intervention and outcomes, the type of laser therapy equipment, 
its setting, the method and frequency of its use of placement of laser, where 
recalculation was done for laser characteristics and dosage based on the 
data published on each study. The calculation aimed to obtain data of 
irradiance (mW/cm2) and dose (J) for each study if not provided, or 
presented in different unit, see appendix 3 for calculation formula. During the 
process of data extraction, authors were not blind to the aims of the study.  
---------------------------------------------insert figure 1-------------------------- 
Analysis 
Meta-analysis was not possible due to the clinical heterogeneity of study 
design and intervention protocols, where clinical heterogeneity was 
considered by table 2. 
---------------------------------------------insert table 2--------------------------------------- 
Due to insufficient amount of published data available, statistical 
heterogeneity was not tested, therefore a narrative synthesis was conducted. 
The authors critically appraised each article matching all inclusion and 
exclusion criteria by using Critical Appraisal Skills Programme Tools (CASP 
UK, 2013) and The Cochrane Collaboration’s tool for assessing risk of bias 
(Furlan et al., 2015) 
 
For the review purpose, the authors selected 15mm change in pain on a 
100mm pain scale as an absolute cut-off as Ostelo et al. (2008) suggested 
and approximately 6-point change in ODI (Fritz and Irrgang, 2001), as 
minimal clinically important difference (MCID).  
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Results 
Description of Studies 
See: Characteristics of included studies (appendix 4a); Characteristics of 
excluded studies (appendix 4b) 
 
Throughout the literature search (figure 1), one hundred and seventy-one 
studies were identified. Among these studies, seven of them met the 
inclusion and exclusion criteria but only six studies (n=379) are included for 
data synthesis in this review, as one study (n=80) (Timimi et al., 2010) was 
excluded due to poor methodology. A summary of baseline characteristics of 
participants in each study is presented in table 3. Among these six studies, 
two of them (Fiore et al., 2011; Alayat et al., 2014) investigated the effect of 
HLLT while four of them (Basford et al., 1999; Gur et al., 2003; Djavid et al., 
2007; Ay et al., 2010) investigated the effect of LLLT. The population 
included in the trials had a diagnosis of CLBP but differed in distribution in 
age and in gender, duration of pain, initial intensity of pain and initial 
functional disability.  
---------------------------------------------insert table 3----------------------------------- 
Risk of bias 
The Cochrane Collaboration’s tool for assessing risk of bias (Furlan et al., 
2015) was adapted in this review and a summary of risk of bias for included 
studies is presented in table 4. Critical Appraisal Skills Programme Tools 
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(CASP UK, 2013) is also used to evaluate studies’ quality. 
---------------------------------------------insert table 4---------------------------------- 
All RCTs included scored at least 8 out of 13 in the scoring system for 
assessing risk of bias, where the scores ranged from 6 to 9. For selection 
bias, all RCTs have low risk in random sequence generation; three RCTs 
(Alayat et al., 2014; Ay et al., 2010; Gur et al., 2003) have high risk in 
allocation concealment. For performance and detection bias, three RCTs 
(Gur et al., 2003; Djavid et al., 2007; Fiore et al., 2011) have high risk in 
blinding subjects and only one RCT (Alayat et al., 2014) has high risk in 
blinding assessors, while only one RCT (Basford et al., 1999) has low risk in 
blinding providers. For attrition bias, two RCTs (Gur et al., 2003; Alayat et al., 
2014) did not report drop-outs; and only two RCTs (Djavid et al., 2007; Fiore 
et al., 2011) used an intention-to-treat analysis. All included RCTs have low 
risk in suggestion of selective outcome reporting. For similarity of baseline 
characteristics, avoiding co-interventions or having similar interventions, 
acceptable compliance, all RCTs have low risk in these domains. All RCTs 
have low risk in having similar timing of outcome assessment with the 
exception of one RCT (Basford et al., 1999); all RCTs have low risk in having 
other risks of bias. A summary of result and limitation of each included study 
is also presented on table 5. 
---------------------------------------------insert table 5---------------------------------- 
The effect of intervention – HLLT 
Among the included studies, two studies investigated the effect of HLLT on 
pain relief and improving functional disability (Fiore et al., 2011; Alayat et al., 
2014). Currently, there is no recommendation for HLLT dosage, as this 
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intervention is recently introduced. The Fiore et al (2011) study (n=30) 
compared the short-term effects of HLLT to ultrasound therapy (US) in the 
treatment of CLBP, while Alayat et al. (2014) study (n=72) looked at the 
long-term effect of HLLT, alone or combined with exercise in the treatment of 
CLBP. 
 
Pain intensity 
Both studies (Fiore et al., 2011; Alayat et al., 2014) used VAS as outcome 
measure for pain and found clinically and statistically significant improvement 
in VAS in HLLT and HLLT with exercise groups (all p<0.001). In Fiore et al. 
(2011) study reported their HLLT group had a significant greater reduction in 
pain (VAS) compared with their US group (p<0.005) after 3-week of 
treatment (5 sessions a week); in the Alayat et al. (2014), study although 
there was no significant difference between placebo laser with exercise 
group and HLLT alone group in VAS, the HLLT with exercise group had a 
larger significant improvement in VAS compared with the placebo laser with 
exercise group and the HLLT alone group (all p=<0.001) after 4-week 
treatment and further 8 weeks without any intervention. Their result also 
showed a significant incline in VAS after that 8 weeks without any 
intervention but the overall improvement in VAS was still significantly better 
when compared to baseline. 
 
Functional disability 
Fiore et al. (2011) study used ODI (Fairbank and Pynsent, 2000) to evaluate 
the effect of HLLT on functional disability and the findings showed both 
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clinically and statistically significant reduction when compared to their US 
group at the end of the treatment (3-week) (p< 0.005). Alayat et al. (2014) 
used ODI (Fairbank and Pynsent, 2000) and RMDQ (Roland and Fairbank, 
2000) to review the effect of HLLT on function disability, where the result 
showed no statistically significant difference between placebo with exercise 
group and HLLT group at week 4 and 12. However, their HLLT with exercise 
group showed clinically and statistically significant improvement when 
compared to other groups at week 4 and 12 (RMDQ: all p=0.0001; ODI: week 
4: p=0.002, week 12: p = 0.0001) 
   
The effect of intervention – LLLT    
In 2010, the World Association of Laser Therapy (WALT) revised the 
recommended dosage of LLLT for LBP. Among the included studies, four 
RCTs (Basford et al., 1999; Gur et al., 2003; Djavid et al., 2007; Ay et al., 
2010) (n=277) investigated the effect of LLLT on pain relief and improving 
functional disability, where three RCTs (Gur et al., 2003; Djavid et al., 2007; 
Ay et al., 2010) matched with the WALT (2010) recommendation and 
although one RCTs  (Basford et al., 1999) did not use pulsed waveform as 
recommended, their findings showed positive result in both pain relief and 
improving functional disability.  
 
Basford et al. (1999) (n=61) study compared the effect between LLLT group 
and placebo laser group on CLBP; Gur et al. (2003) (n=75) investigated the 
efficacy of LLLT and exercise on pain and function on CLBP with a trial 
design of three groups: LLLT with exercise group, LLLT alone group and 
Page 13 
 
exercise alone group; Djavid et al. (2007) (n=61) did a similar trial as Gur et al 
(2003) but the exercise alone group was replaced with a placebo laser with 
exercise group. Ay et al. (2010) (n=80) study included four arms of trial for 
acute and chronic lumbar herniation (two arms each); however, this review 
only included their results from the chronic lumbar disc herniation groups 
(n=40) which were sub-divided into hot pack and LLLT, and hot pack and 
placebo laser group. Although the population had a diagnosis of lumbar disc 
herniation, current recommended low back pain referral pathway (The Royal 
College of Surgeons of England, 2013) does not refer patients for 
radiographical investigation unless patients present with severe and/or 
progressive neurological deficits or unsettling pain after primary care (at 4-6 
weeks with treatment). Thus, the diagnosis of lumber disc herniation is not 
yet confirmed by radiographical investigation when they receive 
physiotherapy in primary care. Since Ay et al. (2010) also excluded patients 
with any neurological deficits; therefore their result is still included into this 
review. 
 
Pain intensity 
All included LLLT RCTs (Basford et al., 1999; Gur et al., 2003; Djavid et al., 
2007; Ay et al., 2010) used VAS (Ogon et al., 1996) as outcome measure for 
pain intensity.  
 
Basford et al. (1999) study’s finding showed clinically and statistically 
significant difference in maximal pain in the last 24 hours between active and 
placebo LLLT groups at week 5 (p = 0.007, differences in mean = -15.7; 95% 
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CI = -14.0, -4.0) and at 1-month follow up (p = 0.012; differences in mean = 
-16.0, 95% CI = -28.4, -3.7), suggesting an analgesic effect can be achieved 
by LLLT.  
 
In the Djavid et al. (2007) study, there was no statistically significant 
difference between LLLT alone group, LLLT with exercise group, placebo 
laser with exercise group in pain relief effect immediately after 6-week 
intervention and after another further 6-week of no intervention (both p > 
0.05); however, in LLLT with exercise group achieved a 18mm more in 
reduction of VAS than placebo laser with exercise group (p= 0.03, 95%CI = 
-0.2, -1.8) after another further 6-week of no intervention. This suggested 
LLLT combined with exercise may be more beneficial than LLLT or exercise 
therapy alone as it reached the selected MCID (15mm) in this review.  
 
In the Gur et al. (2003) study, all treatment groups showed clinically and 
statistically significant decrease in pain intensity after therapy (p<0.05). 
Although there was no significant between-group difference, they reported 
pain levels in LLLT with exercise and LLLT alone groups decreased more 
than the exercise alone group in their trial (no data provided). Therefore, 
LLLT can be an effective method in reducing pain for CLBP. 
 
Ay et al. (2010) findings showed clinically and statistically significant 
improvement in VAS in all CLBP groups: hot pack with laser therapy and with 
placebo lasers group (p<0.001); however no significant difference was 
detected in this RCT between groups (p=0.405).  
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Functional disability 
All of the LLLT RCTs (Basford et al., 1999; Gur et al., 2003; Djavid et al., 2007; 
Ay et al., 2010) used ODI (Fairbank and Pynsent, 2000) as functional 
disability outcome measure, while Ay et al (2014) used ODI and RMDQ 
(Roland and Fairbank, 2000).  
 
Basford et al. (1999) (n=56) reported that there was clinically and statistically 
significant reduction in ODI in LLLT group when compared to baseline (all 
p<0.05), and between LLLT and placebo laser group at 5-week follow-up and 
1-month follow-up (after 5-week treatment: p=0.001, difference in mean = 
-9.3, 95%CI = -14.7, -4.0) (at 1-month follow-up: p=0.004, difference in mean 
= -8.2, 95%CI = -13.6, -2.8). An insignificant increase of about 1 point in ODI 
at LLLT group was noted when compared the result of after 5-week treatment 
and at 1-month follow-up. These findings suggested LLLT can improve 
functional disability with CLBP; however, the effect could be limited and lost 
over time. 
 
Djavid et al. (2007) study (n=61) reported that LLLT alone, LLLT with exercise 
and placebo laser with exercise group all showed clinically and statistically 
significant improvement in individual groups between week 0, week 6 and 
week 12 (all p<0.05). There was no between-group difference for functional 
disability immediately after 6-week treatment and after a further 6 week of no 
intervention. However, LLLT with exercise group reduced 9.4 point more 
(p=0.03, 95%CI = -0.1, -3.3) in ODI than in the placebo laser with exercise 
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group after another 6 weeks of no intervention. Their result suggested LLLT 
with exercise is more effective in improving disability in the long term.  
 
Conversely, another two studies (Gur et al, 2003; Ay et al, 2010) (n=115) did 
not support Basford et al. (1999) and Djavid et al. (2007) findings (n=117). In 
the Gur et al (2003) study (n=75), all treatment groups showed clinically and 
statistically significant improvement in ODI in individual group when 
compared to their baseline (p<0.05); however, there was no between–group 
difference (p>0.05). Similarly, in Ay et al. (2010) study (n=40), all treatment 
groups achieved clinically and statistically significant improvement in ODI 
(p<0.001) and RMDQ (p=0.001) in all individual groups but no statistically 
significant difference was found between groups (p>0.05).  
 
Discussion 
This review has found that HLLT has a significant positive analgesic effect on 
CLBP and improve functional disability on CLBP after 4-week treatment and 
another 8 weeks without any intervention (Fiore et al., 2011; Alayat et al., 
2014); the therapeutic effect may decrease with time but there is still 
significant improvement at week 12 when compared to baseline. It might be 
more effective when combined with personalised exercise programme. 
However, the total sample from their studies is too small (n=103) for a 
conclusion to be drawn. This review has also found that LLLT (n=277) 
(Basford et al., 1999; Gur et al., 2003; Djavid et al., 2007; Ay et al., 2010) with 
exercise may be superior to LLLT alone or exercise alone group in pain relief 
effect and improving functional disability; however, the difference was not 
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always statistically significant. HLLT and LLLT are not currently to be 
replaced or be offered in addition to conventional treatment. Further rigorous 
research is required to confirm the potential use of laser therapy on 
individuals presenting with CLBP. 
 
Among all RCTs included, there was only one RCT (Basford et al., 1999) 
specifically described how pain intensity was measured by VAS, for example: 
pain at rest or maximal pain in 24 hours, whereas other included studies did 
not. Standardising the measurement of VAS in CLBP patients would allow 
more rigorous comparison between trials.  
 
The findings from this review also suggest that a significant reduction in pain 
in CLBP patients who received laser therapy does not necessarily lead to a 
significant increase in function. This matches with the findings from Kovacs et 
al. (2004) (n=195) who reported that ODI has a weak correlation with VAS in 
CLBP population (r = 0.103), where RMDQ correlated better with VAS (r = 
0.570). This could be explained by the findings from Thomas et al. (2010) 
(n=50): psychosocial factors are strongly associated with disability and 
altered quality of life in chronic low back pain patients, whereas ODI focuses 
more on activity while RMDQ has more psychosocial aspect.  
 
Yousefi-Nooraie et al. (2007) conducted a systematic review and concluded 
there were insufficient data to either support or refute the effectiveness of 
LLLT for the treatment of both acute and chronic LBP; however, they did not 
evaluate the effectiveness of HLLT. There are other systematic reviews that 
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investigated the effectiveness of laser therapy. Kadhim-Saleh et al. (2013) 
concluded the effectiveness of LLLT on relieving neck pain is inconclusive 
because of heterogeneity and potential risk of bias. Another systematic 
review (Brosseau et al., 2005) evaluated the effectiveness of LLLT on 
rheumatoid arthritis LLLT can relief pain and stiffness in short-term but there 
is need to further investigate the parameters of LLLT to maximise its 
effectiveness. Jang and Lee (2012) conducted a meta-analysis on pain relief 
effects by laser irradiation on joint areas and they found applying LLLT on the 
joint can reduce pain in patients. Chow et al (2009) conducted a systematic 
review and meta-analysis of randomised placebo or active-treatment 
controlled trials on efficacy of LLLT in the management of neck pain and 
concluded that LLLT reduced pain immediately after treatment in acute neck 
pain, and up to 22 weeks after completion of treatment, in patients with 
chronic neck pain. To conclude, LLLT can reduce pain caused by 
musculoskeletal problems but its benefits in improving functional disability 
are still inconclusive; no review has evaluated the effectiveness of HLLT. 
 
HLLT versus LLLT 
The use of LLLT has been over decades (Moshkovska and Mayberry, 2005) 
while the trend of laser therapy has been to increase dosage and the use of 
HLLT was introduced 9 years ago (Wartz, 2006).Theoretically, a biphasic 
response in LLLT was observed in both in vivo and in vitro studies (Huang et 
al., 2011); therefore the dose of HLLT would be too high and may cause 
damage on the target tissue rather than healing it. 
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A preliminary literature search on different databases revealed there is only 
one RCT (Kheshie et al., 2014) that compared the effectiveness of HLLT and 
LLLT in patients with osteoarthritis of the knee. Kheshie et al., (2014) 
reported HLLT is more effective than LLLT in pain relief and improvement in 
functional disability in treating patients with osteoarthritis of the knee. Further 
research is required to compare the effectiveness between LLLT and HLLT. 
 
Conclusion 
Implication for practice 
Based on this review’s findings, HLLT is more beneficial for pain relief and 
improving functional disability in patients with CLBP when compared to 
placebo treatment and ultrasound therapy; however, due to the small total 
sample size (n=103), HLLT with and without exercise is not recommended to 
replace conventional treatment. Current findings from four RCTs (n=277) 
suggest LLLT achieves better pain relief effect and greater improvement in 
functional disability, despite the effect is not always statistically significant 
when compared to other treatment groups. Therefore, LLLT with and without 
exercise is also not recommended to replace conventional treatment either. 
  
Implication for research 
More research with rigorous methodology is required to further investigate 
the effect of HLLT and LLLT in the management of CLBP. Comparison 
between HLLT and LLLT is recommended.   
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Key messages: 
1. HLLT is not recommended to replace conventional therapy because 
although current evidence indicates a statistically significant 
improvement on the selected patient reported outcome measures, the 
total sample size of this review for HLLT was small. 
2. LLLT is not recommended to replace conventional therapy as current 
evidence does not show statistically significant improvement on the 
selected patient reported outcome measures. 
3. More rigorous research is required to investigate the effect of HLLT and 
LLLT on the management of CLBP; comparison between HLLT and LLLT 
is also recommended. 
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Appendix 1 - Search Strategy for databases 
MH “Low back pain” 
1. MH “back pain”  
2. “lower back pain” 
3. “Lumbar back pain” 
4. 1 OR 2 OR 3 OR 4 
5. MH “Laser therapy” 
6. MH “laser therapy, low-level” 
7. “cold laser therapy” 
8. “Infrared laser therapy” 
9. “ near-infrared laser therapy” 
10. “high level laser therapy” 
11. “high power laser therapy” 
12. “high intensity laser therapy 
13. “non infrared laser therapy” 
14. 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 
15. 4 AND 14 
 
Key: 
“MH” = Medical Subject Heading 
“OR” = or 
“AND” = and 
 
*further screening was then done manually, please refers to PRISMA 
flowchart (figure 1) 
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Appendix 2 – Inclusion and exclusion criteria 
Inclusion criteria 
1. Randomized controlled trials (RCTs) 
2. English language available 
3. Available at AMED; CINAHL; Cochrane Library; MEDLINES; and 
PEDRO all from the start of each database to November 2014.   
4. Full text available  
5. Match the search terms (appendix 1) 
6. Has at least one validated patient reported outcome measure to 
investigate pain intensity and/or functional disability 
7. Population aged more than 17 years old but less than 60 years 
old 
8. Studies that included laser intervention with or without other 
intervention either as a co-intervention or stand alone 
 
Exclusion criteria 
1. Non-RCTs 
2. using laser acupuncture as primary intervention 
3. total sample size is smaller than 20 or equal to 20 
4. scored less than 8 out of 13 in The Cochrane Collaboration’ s 
tool for assessing risk of bias (2015 Updated) 
5. acute low back pain or equivalent 
6. pain is considered to be originated from an extraspinal source  
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Appendix 3 - Laser therapy dosage calculation 
 
Glossary: 
Fluency (H):  it is equivalent to the energy density (joules/cm2), at a point 
of a surface, the radiant energy incident on an element of 
the surface, divided by the area of the surface. 
Irradiance (E):  At a point of a surface, the radiant energy flux (or power) 
incident on an element of the surface, divided by the area 
of the surface. 
Total energy (JT): The total energy delivered throughout the treatment  
Time (s):  Time or duration  
 
Equations: 
 
Fluency (j/cm2)  = total amount of energy (j) / area (cm2) 
 
Total energy (j) = average power (W) x Time (s), when it is continuous 
waveform      
 
 
 
 
 
 
z 
when it is pulsed 
waveform, where tP 
– t0 = pulse 
duration 
Irradiance (W/cm2) = 
0 
 
 
Appendix 4 - Characteristics of Studies 
 
Appendix 4a – Characteristics of Included Studies 
 
Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Methods 
Study Design RCT RCT RCT RCT RCT RCT 
Unit of Allocation Patients Patients Patients Patients Patients Patients 
Method of 
randomisation 
Using Graphpad 
program 
By numbered 
envelopes method 
By computer-generated 
schedule 
Using block randomisation 
with a manual schedule 
Not stated Not stated 
Allocation 
concealment 
No No Yes Yes Yes No 
Blindedness 
Single blinded 
(patient) 
Single blinded (patient 
and assessor) 
Double blinded 
Single blinded (assessor 
blinded) 
Single blinded 
(assessor blinded) 
Single blinded (assessor 
blinded) 
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Appendix 4a – Characteristics of Included Studies 
 
Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Participants 
Number 
Randomised = 72; 
Analysed = 72 
Randomised = 80 
Analysed = 80 
Randomised = 63 
Analysed = 56 
Randomised = 61 
Analysed = 53 
Randomised = 30 Analysed = 
30 
Randomised = 75 
Analysed = 75 
Recruitment of 
patients 
From the male section 
of the rehabilitation of 
their hospital 
Not stated 
Recruited with 
announcements in their 
institutional newspaper and 
local newspaper and by 
referral from local 
physicians and 
chiropractors 
Referred by local 
physicians to the clinic 
of an Occupational 
Medicine Department 
Consecutive outpatients 
attending the Department of 
Physical medicine and 
Rehabilitation, University of 
Foggia 
Patients admitted to 
Dicle University, Faculty 
of Medicine, Physical 
Medicine and 
Rehabilitation 
Department 
Enrolment dates Not stated Not stated Not stated Not stated 
From June 2009 to January 
2011 
From May 1999 to March 
2000 
Age 
Between the age of 20 
and 50 
Not stated 
Between the age of 18 and 
70 
Between the age of 20 
and 60 
Between the age of 20 and 60 
Between the age of 20 
and 50 
Sex Male Male and female Male and female Male and female Male and female Male and female 
Ethnicity Not stated Not stated Not stated Not stated Not stated Not stated 
Work status Not stated Not stated Not stated Not stated Not stated Not stated 
Diagnosis of 
LBP 
Based on history and 
physical examination 
Lumbar disc herniation, 
based on clinical 
examination 
Non-radiating 
musculoskeletal low back 
pain, based on clinical 
examination 
Based on clinical 
examination from 
referrers 
The presence of lumbar pain at 
rest, or pain during movement 
of the lumbar spine, absence of 
sciatica 
Clinically and 
radiologically diagnosed 
as CLBP 
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Alayat et al, 2014 Ay et al, 2010 
Basford et al, 
1999 
Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Participants 
Duration of 
Pain 
At least 1 year history of 
LBP 
Not stated 
At least 1 month 
history of LBP 
At least 12 week history 
of LBP 
At least 3 week history of LBP 
At least 12 month 
history of LBP 
Previous 
treatment 
Not stated Excluded those had surgery 
Excluded those 
had treatment of 
this problem in the 
previous 30 days 
or had spinal 
surgery 
Not stated 
No other physiotherapy intervention in the 4 
weeks prior to the study 
Not stated 
Exclusion 
criteria 
Any history of spinal 
surgery, any 
degenerative disc 
disease, any disc 
herniation, spine 
fracture, spondylosis, 
spinal stenosis, 
neurological deficits, 
abnormal laboratory 
findings, and systemic 
and psychiatric illnesses 
were excluded 
Any history of spinal 
surgery, any degenerative 
disc disease, any 
neurological deficit, any 
spondylosis, any spinal 
stenosis, any 
spondyloisthesis, any 
pregnancy and any 
inflammatory, infectious, or 
malignant disease, and 
history of spinal surgery 
were excluded 
Any radicular pain, 
any neurological 
deficits, any 
litigation or 
workman’s 
compensation was 
pending, any 
intake of 
corticosteroid in 
the previous 30 
days 
Any history of spinal 
surgery, any 
degenerative disc 
disease, any disc 
herniation, spine 
fracture, spondylosis, 
spinal stenosis, 
neurological deficits, 
abnormal laboratory 
findings, and systemic, 
psychiatric illnesses and 
pregnancy were 
excluded 
Any patients, with anaesthetic or 
corticosteroid injection within 4 weeks of 
study enrolment, radicular pain, 
osteoporosis, surgery or previous fracture 
of spine, spinal stenosis, a history of acute 
trauma, known osteoarthritis, myofascial 
pain syndrome, inflammatory rheumatic 
disease, systemic lupus erythematosus, 
diabetes mellitus type 1 or 2, thyroid 
dysfunction, obesity, pace-maker, 
neurological pathologies and 
anxious-depressive syndromes were 
excluded 
Patients with 
pregnancy, any 
neurological 
deficits, any 
abnormal 
laboratory findings 
and systemic and 
psychiatric illness 
were excluded 
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Alayat et al, 2014 Ay et al, 2010 
Basford et al, 
1999 
Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Interventions 
Groups 
HLLT with exercise 
(n=28); HLLT only 
(n=24); placebo 
laser with exercise 
(n=24) 
Acute lumbar disc herniation 
with hot-pack + LLLT (n=20); 
Acute lumbar disc herniation 
with hot-pack + placebo laser 
(n=20); chronic lumbar disc 
herniation with hot-pack + LLLT 
(n=20); chronic lumbar disc 
herniation with hot-pack + 
placebo laser (n=20); 
LLLT group (n=27); 
Placebo laser group 
(n=29) 
LLLT group (n=16); LLLT 
with exercise group (n=19); 
placebo laser with exercise 
group (n=18) 
HLLT group (n=15); 
ultrasound (US) group 
(n=15) 
LLLT with exercise group 
(n=25); LLLT alone group 
(n=25); exercise alone group 
(n=25) 
Laser 
setting 
Sessions 
3 sessions per week 
for 4 weeks 
5 sessions per week for 3 
weeks 
3 sessions per week 
over 4 weeks 
2 sessions a week over 6 
weeks 
5 sessions a week 
over 3 weeks 
5 sessions a week over 4 
weeks 
Laser 
Medium 
Neodymium 
YAG(Nd: YAG) laser 
Gallium-Aluminium-Arsenide 
(GaAIAs) laser 
Neodymium 
YAG(Nd: YAG) laser 
Gallium-Aluminium-Arsenide 
(GaAIAs) laser 
Neodymium YAG(Nd: 
YAG) laser 
Gallium-Aluminium-Arsenide 
(GaAIAs) laser 
Laser model 
HIRO 3 device (ASA 
laser) 
Infrared diode laser device 
(Chattanooga group USA) 
Not stated Not stated HIRO1.0 (ASA laser) 
Frank Line IR 30(Fysiomed, 
Belgium) 
Wavelength 1064 nm 850 nm 1060 nm 810 nm 1064 nm Not stated 
Laser mode Pulsed Continuous Continuous Continuous Pulsed Pulsed 
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Interventions 
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Laser 
setting 
Pulse 
frequency 
10-40 Hz 
16 Hz (for acute); 
155 Hz (for 
chronic) 
Not stated Not stated Not stated 2100 Hz 
Pulse 
duration 
120-150 μs Not stated Not stated Not stated Less than 15000 μs Not stated 
Peak power 3000 W Not stated Not stated Not stated 1000 W Not stated 
Average 
power 
3.33 W 0.1 W 0.11 W 0.11 W 6W 0.0042 W 
Average 
irradiance 
54W/cm
2
 Not stated 0.542 W/cm
2
 Not stated Not stated 
Not stated and not 
enough data to 
calculate 
Fluency 0.510 – 1.780 J/cm
2
 40 J/cm
2
 
Not stated and not 
enough data to calculate 
27 J/cm
2
 0.760 J/ cm
2
 1 J/cm
2
 
Laser class Not stated Not stated Not stated Not stated Not stated IIIb 
Spot area 0.2 cm
2
 0.07 cm
2
 4.01 cm
2
 0.22 cm
2
 0.2 cm
2
 1.0 cm
2
 
Application 
time 
15 mins 4 mins per point 90 sec per two points About 20 mins About 10 mins About 30 mins 
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Interventions 
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Laser 
setting 
Anatomical 
location 
Lower back area of 
L1-L5 and S1 
2 – 4 points over 
both sides of the 
paraspinal 
tissues of the 
disk spaces 
Irradiating two points 
simultaneously at each 
of four equally spaced 
level; two sites at each of 
four equally spaced 
levels along the L2 to S3 
paraspinal tissues 
A series of standardised 
fields designed to include 
the L4 to L5 and L5 to S2 
apophyseal capsules, 
dorsolumbar fascia, and 
interspinous ligaments, as 
well as the gluteal fascia, 
posterior sacroiliac 
ligaments, hamstrings, and 
gastro-soleus muscles of 
which pain points were 
palpated form the low back 
to the foot. 
Stage 1: fast manual 
scanning on the zones of 
muscular contractures, 
particularly on the lumbar 
and dorsal muscles, 
latissimus dorsi, external 
oblique abdominis and 
gluteus maximus; Stage 2: 
on the trigger point found 
until a pain reduction of 
70-80% achieved; stage 3: 
same as stage 1 but slow 
manual scanning. 
A series of standardised fields 
designed to include the L4 to 
L5 and L5 to S2 apophyseal 
capsules, dorsolumbar fascia, 
and interspinous ligaments, 
as well as the gluteal fascia, 
posterior sacroiliac ligaments, 
hamstrings, and 
gastro-soleus muscles of 
which pain points were 
palpated from the low back to 
the foot 
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Interventions al, 1999 
Other combined treatment 
Exercises included 
strengthening, 
stretching, mobilising, 
coordinating and 
stabilising the 
abdominal, back and 
pelvic muscle but they 
were personalised for 
each patient’s clinical 
finings 
Hot-pack: 20 
mins per session 
Not applicable 
Home exercise program 
that might include 
strengthening, 
stretching, mobilising, 
coordination and the 
stabilising of the 
abdominal, back, pelvic, 
and lower limb muscles, 
depending on the clinical 
findings 
Ultrasound (US) group (n=15): 
5 times a week over 3 weeks; 
US model: SONOPLUS 492 
(Enraf-Nonius BV); US 
frequency = 1MHz; US 
intensity = 2W/cm
2
 with a duty 
cycle of 100%; transducer 
head area = 5.8cm
2
; effective 
radiating area = 4.6cm
2
; 
anatomical location: over the 
lumbar and dorsal muscles, 
latissimus dorsi , external 
oblique adbominis and gluteus 
maxius, covering about 
150cm
2
 
Exercise: lumbar flexion and 
extension, knee flexion, hip 
adduction exercises and strength 
exercises on extremity muscle 
group were give two sessions a day 
(total 40 session over 4 weeks), 
where the first exercise session 
was conducted with a 
physiotherapist and continued at 
home by patients themselves 
Placebo treatment or 
other single treatment 
Placebo irradiation 
with deactivated laser 
radiation. Received 
before applying 
exercises 
Same as 
experimental 
group but 
applied without 
turning on the 
device 
Same protocol 
as LLLT but 
using inactive 
device 
Same protocol as LLLT 
but using inactive device 
and carrying out 
exercise with the same 
protocol as LLLT with 
exercise group 
Not applicable 
LLLT alone group: same protocol as 
LLLT with exercise group but 
without exercise 
Exercise alone group: same 
protocol as LLLT with exercise 
group but without LLLT 
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Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 
Djavid et al, 
2007 
Fiore et al, 2011 Gur et al, 2003 
Outcomes 
Measurement by Not stated Not stated Physicians Physicians Not stated Physicians 
Measured variables 
Pain (VAS), lumbar 
range of movement, 
functional disability 
(RDQ and ODS) 
Pain (VAS), lumbar range of 
movement and modified 
Schöber test, functional 
disability (RMDQ and ODI) 
Pain (VAS), lumbar 
range of movement, 
patient perception of 
benefits, functional 
disability (ODI) 
Pain (VAS), lumbar 
range of movement 
and Schöber test, 
functional disability 
(ODI) 
Pain (VAS), lumbar range 
of movement and 
Scholber test, functional 
disability (ODS) 
Pain (VAS), lumbar 
range of movement 
(flexion and lateral 
flexion) and 
Scholber test, 
functional disability 
(ODI) 
Follow-up session 
8 week after 4-week 
treatment 
No follow-up after completion of 
treatment 
1 month after 4-week 
treatment 
6 weeks after 
6-week treatment 
3 week mark (after the 
whole course of 
treatment) 
1 month after 4-week 
treatment 
Intention-to-treat 
analysis 
No No No Yes Yes No 
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Appendix 4a – Characteristics of Included Studies 
 
 
Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 
Djavid et al, 
2007 
Fiore et al, 2011 Gur et al, 2003 
Notes 
Total score 8 / 13 10 / 13 11 / 13 11 / 13 11 / 13 8 / 13 
Limitation 
All participants were 
male; the exercise 
program for individual 
was personalized and 
monitored by 
participant's family 
members, therefore the 
exercise intensity could 
be varied 
Hot-pack was used in each 
group, leading to potential mask 
effect; unknown peak output of 
laser therapy;  unknown 
optimum irradiance; short 
follow-up duration; no placebo 
group alone; participants were 
not blinded 
Unknown optimal 
treatment parameters 
Small sample size 
to detect change in 
some outcomes; no 
power calculation 
prior to the trial; no 
data provided to 
compare the 
effectiveness 
between 
low-intensity laser 
therapy group and 
low-intensity laser 
therapy plus 
exercises group 
Relatively small sample 
size: n = 30(15/15); 
demographic information 
was not clearly presented; 
participants were not 
blinded; no control group; 
time effect may contribute 
into the result; lack of 
follow-up post-3-week 
period 
No concealed 
allocation; 
participants and 
therapists were not 
blinded; no 
intention-to-treatment 
analysis; inadequate 
follow-up;  unknown 
optimum irradiance 
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Appendix 4a – Characteristics of Included Studies 
 
 
Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Risk of 
bias 
Authors’ 
judgement 
Support 
for 
judgement 
Authors’ 
judgement 
Support 
for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support 
for 
judgemen
t 
Authors’ 
judgement 
Support for 
judgement 
Adequate 
sequence 
generation
? 
Low risk  Low risk  Low risk  Low risk  Low risk  Low risk  
Allocation 
concealme
nt? 
High risk  High risk  Low risk  Low risk  Low risk  High risk  
Blinding? 
All 
outcomes 
– patients? 
Low risk  Low risk  Low risk  High risk 
The laser 
therapy 
alone group 
was not 
blinded 
Low risk  High risk  
Ap endix 4a – Characteristics of Included Studies 
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Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Risk of bias 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support 
for 
judgement 
Blinding? All 
outcomes – 
providers? 
High risk  High risk  Low risk  High risk 
Authors do 
not think 
wearing 
googles 
can 
achieve 
blinding 
Low risk  High risk  
Blinding? All 
outcomes – 
outcome 
assessors? 
High risk  Low risk  Low risk  Low risk  Low risk  Low risk  
Incomplete 
outcome data 
addressed? All 
outcomes – 
drop-outs? 
Unknown 
risk 
Not stated 
in text 
Low risk  Low risk 
Drop-out 
number 
and 
reasons 
were 
stated in 
text 
Low risk  Low risk  High risk Not stated 
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Page 12 
 
 
 
 
 
 
Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Risk of bias 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
In complete 
outcome data 
addressed? All 
outcomes – ITT 
analysis? 
High risk  High risk  High risk 
Patients 
who 
dropped 
out were 
not 
included 
into 
analysis 
Low risk  Low risk  High risk  
Suggestion of 
selective 
outcome 
reporting? 
Low risk  Low risk  Low risk  Low risk  Low risk  Low risk  
Suggestion of 
selective 
outcome 
reporting? 
Low risk  Low risk  Low risk  Low risk  High risk  Low risk  
Similarity of 
baseline 
characteristics? 
Low risk  Low risk  Low risk  Low risk  High risk  Low risk  
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Appendix 4b - Characteristics of Excluded Studies 
 
 
Alayat et al, 2014 Ay et al, 2010 Basford et al, 1999 Djavid et al, 2007 Fiore et al, 2011 Gur et al, 2003 
Risk of bias 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Authors’ 
judgement 
Support for 
judgement 
Co-interventions 
avoided or 
similar? 
Low risk  Low risk  Low risk  Low risk  Low risk  Low risk  
Compliance 
acceptable? 
Low risk  Low risk  Low risk  Low risk  Low risk  Low risk  
Timing outcome 
assessments 
similar? 
Low risk  Low risk  
Unknown 
risk 
Various 
follow-up 
duration 
from initial 
visit, noted 
from fig 1 
in the 
article 
Low risk  Low risk  Low risk  
Any other risks 
of bias? 
Low risk  Low risk  Low risk  Low risk  Low risk  Low risk  
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Timimi et al, 2014 
Methods 
Study Design RCT 
Unit of Allocation Patients 
Method of randomisation Using block randomisation with a manual schedule 
Allocation concealment Yes 
Blindedness Therapist blinded only 
Participants 
Number Randomised = 80; analysed = 80 
Recruitment of patients Recruited via referral of local physicians to the clinic of an Occupational Medicine Department 
Enrolment dates Not stated 
Age Between the age of 20 and 60 
Sex Male and Female 
Ethnicity Not stated 
Work status Not stated 
Diagnosis of LBP Not stated 
Duration of Pain At least 12 week history of LBP 
Previous treatment Not stated 
Exclusion criteria 
Patients with degenerative disc disease, disc herniation, fracture, spondylosis, and spinal 
stenosis, neurological deficits, abnormal laboratory findings, systemic or psychiatric illness, and 
pregnancy were excluded 
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Timimi et al, 2014 
Intervention 
Groups LLLT with exercise group (n=25); placebo laser with exercise (n=30); exercise group (n=25) 
Laser setting 
Sessions 3 sessions a week for 4 weeks 
Laser Medium Gallium-Aluminium-Arsenide(GaAIAs) laser 
Laser model Not stated 
Wavelength 760 nm 
Laser mode Continuous  
Pulse frequency Not applicable 
Pulse duration Not applicable 
Peak power Not stated 
Average power 10 mW 
Average irradiance Not stated 
Fluency 40 J/cm
2
 
Laser class Not stated 
Spot area 0.2211 cm
2
 
Application time 20 mins 
Anatomical location 
a series of standardised fields designed to include the L4 to L5 and L5 to S2 apophyseal capsules, dorsolumbar fascia, 
and interspinous ligaments, as well as the gluteal fascia, posterior sacroiliac ligaments, hamstrings, and gastro-soleus 
muscles of which pain points were palpated from the low back to the foot 
Other combined treatment 
Exercise: included strengthening, stretching, moblising, coordinating, and stabilizing the abdominal and back muscle. 
The first exercise session was conducted with physiotherapist for 1
st
 session before continued exercising at home. 
Placebo treatment or other single treatment Placebo irradiation with deactivated laser radiation. Followed the same exercise regime as LLLT with exercise group 
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Timimi et al, 2014 
Outcomes 
Measurement by Not stated 
Measured variables Pain (VAS), lumbar range of movement, functional disability 
Follow-up session At week 4 after the last session of intervention 
Intention-to-treat analysis No 
Notes 
Total score 6 / 13 
Limitation 
Did not provide baseline characteristic of each treatment group; the study only reports the percentage of patients who improved without clearly reporting the extent 
of improvement; unknown number of subjects included into final data synthesis; patients and assessors were not blinded; unknown drop-out rate; ?effective 
wavelength 
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Appendix 4b - Characteristics of Excluded Studies 
Timimi et al, 2014 
Risk of bias 
Bias Authors’ judgement Support of judgement 
Adequate sequence generation? Low risk  
Allocation concealment? Low risk  
Blinding? All outcomes – patients? High risk  
Blinding? All outcomes – providers? Low risk  
Blinding? All outcomes – outcome assessors? High risk  
Incomplete outcome data addressed? All outcomes – drop-outs? 
High risk 
The number of patients included into data analysis was not 
stated in text 
In complete outcome data addressed? All outcomes – ITT 
analysis? 
High risk  
Suggestion of selective outcome reporting? 
High risk 
The study only reports the percentage of patients who 
improved without clearly reporting the extent of improvement. 
Similarity of baseline characteristics? 
High risk 
Demographic information and initial findings from 
pre-treatment were not presented in text 
Co-interventions avoided or similar? Low risk  
Compliance acceptable? Unknown risk No information provided in text 
Timing outcome assessments similar? Low risk  
Any other risks of bias? Low risk  
0 
 
Table and figure 
 
 
 
 
 
Table 1 – Population-Intervention-Comparison-Outcome-Study 
Population Individuals, who  aged 18 years old or above but less 
than 60 years old , with diagnosis of chronic or 
persistent non-specific low back pain with/without 
referred symptom 
Intervention Any form of laser therapy 
Comparison  Laser therapy with/without exercise, placebo laser 
therapy or other treatment group 
Outcomes Any validated outcome measure for assessing pain 
intensity; any validated outcome measure for 
assessing functional disability 
Study Randomised controlled trials (RCTs)  
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Figure 1 – PRISMA Flowchart 
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Table 2 – Factors that are considered to determine clinical heterogeneity 
1. Methodological study quality; 
2. Population differences in age and gender; 
3. Duration of symptoms; 
4. Severity of symptoms; 
5. LBP aetiology; 
6. Intervention type by laser class, treatment protocol (e.g. irradiance 
and fluency), treatment duration and irradiation sites; 
7. Outcomes (i.e. subjective report of pain, range of movement, 
functional disability measures, or other measures of performance) 
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